Study protocol of an exercise and nutrition intervention for ovarian cancer patients during and after first-line chemotherapy (BENITA) - a randomized controlled trial von Maurer, Tabea, Belau, M H, Zyriax, B-C, Welsch, G, Jagemann, B, Chang-Claude, J, Daubmann, A, Buchholz, A, Glismann, K, Moeller, A, Sehouli, J, Woopen, H, Wimberger, P, Harter, P, Kaiser, S, Maass, N, Kiechle, M, Engler, T, Schmalfeldt, B, Schulz, H

Volltext

Physical activity in adults with and without rheumatoid arthritis: cross-sectional results from the Survey of Health, Ageing and Retirement in Europe (SHARE) von Belau, MH, Flaßkamp, F, Becher, H, Hajek, A, König, H-H, Baumbach, L

Volltext bestellen

Differences in patterns of sexual assault among female victims preceding and during the COVID-19 pandemic: an analysis of encounters in an emergency department von Klasen, Caroline M., Teltrop, Leandra, Belau, Matthias H., Lohner, Larissa, Ondruschka, Benjamin, Riecke, Kerstin, Reuter, Susanne, Schmalfeldt, Barbara, Wilmes, Sandra, Witzel, Isabell

Volltext

Deprivation and stroke incidence, treatment and mortality in Germany von Belau, M, Becher, H, Riefflin, M, Bartig, D, Schwettmann, L, Schwarzbach, C J, Grau, A

Volltext

Lapatinib versus trastuzumab in combination with neoadjuvant anthracycline-taxane-based chemotherapy (GeparQuinto, GBG 44): a randomised phase 3 trial von Untch, Michael, Prof, Loibl, Sibylle, MD, Bischoff, Joachim, MD, Eidtmann, Holger, MD, Kaufmann, Manfred, Prof, Blohmer, Jens-Uwe, Prof, Hilfrich, Jörn, Prof, Strumberg, Dirk, Prof, Fasching, Peter A, Prof, Kreienberg, Rolf, Prof, Tesch, Hans, Prof, Hanusch, Claus, MD, Gerber, Bernd, Prof, Rezai, Mahdi, MD, Jackisch, Christian, Prof, Huober, Jens, Prof, Kühn, Thorsten, Prof, Nekljudova, Valentina, PhD, von Minckwitz, Gunter, Prof

Volltext

Evaluation of Mucin-1 protein and mRNA expression as prognostic and predictive markers after neoadjuvant chemotherapy for breast cancer von Sinn, B.V., von Minckwitz, G., Denkert, C., Eidtmann, H., Darb-Esfahani, S., Tesch, H., Kronenwett, R., Hoffmann, G., Belau, A., Thommsen, C., Holzhausen, H.J., Grasshoff, S.T., Baumann, K., Mehta, K., Dietel, M., Loibl, S.

Volltext

A Phase 3 Trial of Bevacizumab in Ovarian Cancer von Perren, Timothy J, Swart, Ann Marie, Pfisterer, Jacobus, Ledermann, Jonathan A, Pujade-Lauraine, Eric, Kristensen, Gunnar, Carey, Mark S, Beale, Philip, Cervantes, Andrés, Kurzeder, Christian, Bois, Andreas du, Sehouli, Jalid, Kimmig, Rainer, Stähle, Anne, Collinson, Fiona, Essapen, Sharadah, Gourley, Charlie, Lortholary, Alain, Selle, Frédéric, Mirza, Mansoor R, Leminen, Arto, Plante, Marie, Stark, Dan, Qian, Wendi, Parmar, Mahesh K.B, Oza, Amit M

Volltext

Survival after neoadjuvant chemotherapy with or without bevacizumab or everolimus for HER2-negative primary breast cancer (GBG 44–GeparQuinto) von von Minckwitz, G., Fasching, P.A., Schrader, I., Kittel, K., Huober, J., Solbach, C., Jackisch, C., Blohmer, J.U., Nekljudova, V., Gerber, B., Groh, U., Villena, C., Liedtke, B., Kittel, K., Mau, C., Potenberg, J., Schilling, J., Just, M., Bückner, U., Doering, G., Feidicker, S., Krabisch, P., Augustin, D., Nestle-Krämling, C., Rezai, M., Höß, C., Terhaag, J., Fasching, P., Staib, P., Aktas, B., Kühn, T., Khandan, F., Möbus, V., Solbach, C., Tesch, H., Stickeler, E., Heinrich, G., Wagner, H., Abdallah, A., Dewitz, T., Emons, G., Belau, A., Rethwisch, V., Lantzsch, T., Müller, V., Holms, F., Müller, T., Deuker, J.-U., Solomayer, E., Runnebaum, I., Link, H., Conrad, B., Feisel-Schwickardi, G., Steinmetz, T., Langanke, D., Ober, A., Fischer, D., Kohls, A., Weikel, W., Bischoff, J., Freese, K., Wiest, W., Sütterlin, M., Dietrich, M., Grießhammer, M., Burgmann, D.-M., Hanusch, C., Rack, B., Salat, C., Sattler, D., Tio, J., Christensen, B., Burkamp, U., Köhne, C.-H., Meinerz, W., Graßhoff, S.-T., Decker, T., Thalmann, I., Sallmann, A., Beck, T., Reimer, T., Bartzke, G., Deryal, M., Weigel, M., Huober, J., Steffens, C.-C., Lemster, S., Stefek, A., Ruhland, F., Hofmann, M., Schuster, J., Clemens, M., Fehm, T., Janni, W., Latos, K., Bauer, W., Roßmann, A., Bauer, L., Hoffmann, G., Schlag, R.

Volltext

Methodological framework for early detection of dengue outbreaks in Tanzania von Belau, M, Boenecke, J, Ströbele, J, Himmel, M, Dretvic, D, Mustafa, U-K, Ahmad, A A, Kreppel, K S, May, J, Becher, H

Volltext

Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer von von Minckwitz, Gunter, Huang, Chiun-Sheng, Mano, Max S, Loibl, Sibylle, Mamounas, Eleftherios P, Untch, Michael, Wolmark, Norman, Rastogi, Priya, Schneeweiss, Andreas, Redondo, Andres, Fischer, Hans H, Jacot, William, Conlin, Alison K, Arce-Salinas, Claudia, Wapnir, Irene L, Jackisch, Christian, DiGiovanna, Michael P, Fasching, Peter A, Crown, John P, Wülfing, Pia, Shao, Zhimin, Rota Caremoli, Elena, Wu, Haiyan, Lam, Lisa H, Tesarowski, David, Smitt, Melanie, Douthwaite, Hannah, Singel, Stina M, Geyer, Charles E

Volltext

MetaCrop 2.0: managing and exploring information about crop plant metabolism von Schreiber, Falk, Colmsee, Christian, Czauderna, Tobias, Grafahrend-Belau, Eva, Hartmann, Anja, Junker, Astrid, Junker, Björn H., Klapperstück, Matthias, Scholz, Uwe, Weise, Stephan

Volltext

LBA29 Final overall survival (OS) results from the phase III PAOLA-1/ENGOT-ov25 trial evaluating maintenance olaparib (ola) plus bevacizumab (bev) in patients (pts) with newly diag... von Ray-Coquard, I.L., Leary, A., Pignata, S., Cropet, C., Martin, A.J. Gonzalez, Bogner, G., Yoshida, H., Vergote, I.B., Colombo, N., Maenpaa, J., Selle, F., Schmalfeldt, B., Scambia, G., Alia, E.M. Guerra, Lefeuvre-Plesse, C., Belau, A., Lortholary, A., Gropp-Meier, M., Pujade-Lauraine, E., Harter, P.

Volltext

A randomized phase III adjuvant study in high-risk cervical cancer: simultaneous radiochemotherapy with cisplatin (S-RC) versus systemic paclitaxel and carboplatin followed by perc... von Sehouli, J., Runnebaum, I.B., Fotopoulou, C., Blohmer, U., Belau, A., Leber, H., Hanker, L.C., Hartmann, W., Richter, R., Keyver-Paik, M.D., Oberhoff, C., Heinrich, G., du Bois, A., Olbrich, C., Simon, E., Friese, K., Kimmig, R., Boehmer, D., Lichtenegger, W., Kuemmel, S.

Volltext

Adjuvant sequential chemoradiation therapy in high-risk endometrial cancer: results of a prospective, multicenter phase-II study of the NOGGO (North-Eastern German Society of Gynae... von Mustea, A., Koensgen, D., Belau, A., Sehouli, J., Lichtenegger, W., Schneidewind, L., Sommer, H., Markmann, S., Scharf, J. P., Ehmke, M., Ledwon, P., Braicu, I., Zygmunt, M., Koehler, G.

Volltext

Abstract P1-13-01: Final results of the ASG1-3 study, a randomized phase III study comparing a standard dose chemotherapy with epirubicin/cyclophosphamide and paclitaxel with a dos... von Fasching, PA, Eggemann, H, Krocker, J, Häberle, L, Volz, B, Kleine-Tebbe, A, Blohmer, J-U, Kittel, K, Hufnagel, M, Janni, W, Emons, G, Simon, E, Köhler, U, Thomssen, C, Kohls, A, Beckmann, MW, Hielscher, C, Krabisch, P, Zeiser, T, Brodkorb, T, Baier, F, Nabieva, N, Kellner, S, Untch, M, Stadie, S, Budner, M, Breitbach, G-P, Keller, M, Stickeler, E, Kühn, T, Tolkmitt, M, Belau, AK, Schmidt, M, Ulm, K, Kümmel, S

Volltext

First-line therapy with moderate dose capecitabine in metastatic breast cancer is safe and active: Results of the MONICA trial von Kaufmann, M, Maass, N, Costa, S.D, Schneeweiß, A, Loibl, S, Sütterlin, M.W, Schrader, I, Gerber, B, Bauer, W, Wiest, W, Tomé, O, Distelrath, A, Hagen, V, Kleine-Tebbe, A, Ruckhaeberle, E, Mehta, K, von Minckwitz, G

Volltext

Phase III PAOLA-1/ENGOT-ov25 trial: Olaparib plus bevacizumab (bev) as maintenance therapy in patients (pts) with newly diagnosed, advanced ovarian cancer (OC) treated with platinu... von Schnelzer, A, Harter, P, Sehouli, J, Canzler, U, Marmé, F, De Gregorio, N, Buderath, P, Lück, HJ, Gropp-Meier, M, Runnebaum, I, Belau, A, Renner, S, Schmalfeldt, B, El-Balat, A, Burges, A, Hillemanns, P, Denschlag, D, Bauerschlag, D, Hanker, L, Ray-Coquard, I

Volltext

P1-14-05: Surgical Complications from the GeparQuinto Trial of Patients Receiving Preoperative Bevacizumab von Eidtmann, H, Kittel, K, Rezai, M, Tesch, H, Ulmer, HU, Stirnberg, S, Belau, A, Mau, C, Stickeler, E, Schrader, I, Fasching, P, Salat, CT, Abdallah, A, Holms, F, Schwedler, K, Nekljudova, V, Loibl, S, von, Minckwitz G

Volltext

Adjuvant sequential chemo-radiation therapy in high-risk endometrial cancer: Results of a prospective, multicenter phase II study of the NOGGO von Koensgen, D., Belau, A., Sehouli, J., Sommer, H. L., Bartz, K., Markmann, S., Schneidewind, L., Scharf, J. P., Ehmke, M., Stengel, D., Ledwon, P., Guba, H., Zygmunt, M., Koehler, G., Mustea, A.

Volltext

Response rate and toxicity of primary concomitant radio-chemotherapy in locally advanced cervical cancer: Results of an open prospective, multicenter phase II study of the NOGGO von Mustea, A., Belau, A., Sehouli, J., Drzewiecki, K., Eichbaum, M. H. R., Bartz, K., Angelidou, E., Saegner, S., Langenbruch, M. O., Ledwon, P., Zygmunt, M., Koehler, G., Koensgen, D.

Volltext